Mind matters coping and cancer progression

Journal of Psychosomatic Research

Volumn 50, Issue 5, 2001, Pages 287-290

  Spiegel, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coping; Depression; Psychosocial oncology

Indexed keywords

ADAPTIVE BEHAVIOR; ARTICLE; ATTITUDE TO HEALTH; DISEASE COURSE; HUMAN; MENTAL STRESS; NEOPLASM; PATHOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOPHYSIOLOGY; QUALITY OF LIFE; SOCIAL SUPPORT;

ADAPTATION, PSYCHOLOGICAL; ATTITUDE TO HEALTH; DISEASE PROGRESSION; HUMANS; NEOPLASMS; PSYCHOPHYSIOLOGY; QUALITY OF LIFE; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 0035345603     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-3999(00)00200-2     Document Type: Review

References (60)

1. Greer S, Morris T, Pettingale KW. Psychological response to breast cancer: effect on outcome. Lancet 1979;2(8146):785-7.
2. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Soc Sci Med 1985;20(8):833-40.
3. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999;354:1331-6.
4. Penninx B, Guralnik JM, Pahor M, Ferrucci L, Cerhan JR, Wallace RB, Havlik RJ. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 1998;90:1888-93.
5. Spiegel D. Living beyond limits. New York: Ballantine/Fawcett, 1994.
6. Spiegel D, Classen C. Group therapy for cancer patients: a research-based handbook of psychosocial care. New York: Basic Books, 2000.
7. Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 1995;52(2):100-13.
8. Spiegel D, Yalom I. A support group for dying patients. Int J Group Psychother 1978;28:233-45.
9. Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry 1981;38(5):527-33.
10. Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 1983;45(4):333-9.
11. Creuss DG, Antoni MH, McGregor BA, Kilbourn KM, Boyers AE, Alferi SM, Carver CS, Kumar M. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med 2000;62:304-8.
12. Taylor SE, Lobel M. Social comparison activity under threat: downward evaluation and upward contacts. Psychol Rev 1989 ;96 (4): 569-75.
13. Spiegel D, Glafkides MC. Effects of group confrontation with death and dying. Int J Group Psychother 1983;33(4):433-47.
14. Spiegal D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;2:888-91.
15. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993;50(9):681-9.
16. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 1990;8(2):356-64.
17. Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer. Cancer 1982;49:1048-55.
18. Ilnyckyj A, Farber J, Cheang M, Weinerman B. A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Physicians Surg Can 1994;27(2):93-6.
19. Cunningham AJ, Edwards CVI, Jenkins GP, Pollack H, Lockwood GA, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-Oncology 1998;7:508-17.
20. Spiegel D. Living beyond limits: new help and hope for facing life-threatening illness. New York: Times Books/Random House, 1993.
21. Kogan MM, Biswas A, Pearl D, Carlson R, Spiegal D. Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma. Cancer 1997;80(2):225-30.
22. Sephton SE, Sapolsky RM, Kraemer HC, Spiegal D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Ins 2000;92:994-1000.
23. Turner-Cobb JM, Sephton SE, Koopman C, Blake-Mortimer J, Spiegal D. Social support and salivary cortisol in women with metastatic breast cancer. Psychosom Med 2000;62:337-45.
24. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 2000;6(6):703-6.
25. Levine S, Lyons DM, Schatzberg AF. Psychobiological consequences of social relationships. Ann N Y Acad Sci 1997;807:210-8.
26. Evans DL, Nemeroff CB. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive sybtypes of melancholia and psychosis. J Psychiatr Res 1987;21:185-94.
27. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984;226(4680):1342-4.
28. Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 1993;150(1):83-6.
29. Heim C, Newport DJ, Graham YP, Wilcox M, Bonsall R, Miller A, Nemeroff C. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA, J Am Med Assoc 2000;284:592-7.
30. Ramirez AJ, Craig TK, Watson JP, Fentiman IS, North WR, Rubens RD. Stress and relapse of breast cancer (see comments). Br Med J 1989;298(6669):291-3.
31. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and health consequences: data and shared mechanisms. Psychosom Med 1995; 57(3):269-74.
32. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as independent predictor of long-term mortality in patients with coronary heart disease (see comments). Lancet 1996;347(8999):417-21.
33. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998;338(3):171-9.
34. Sapolsky R, Armanini M, Packan D, Tombaugh G. Stress and glucocorticoids in aging. Endocrinol Metab Clin North Am 1987;16(4): 965-80.
35. Epel E, McEwan BS, Seeman T, Matthews K, Ickovics J. Psychological stress and lack of cortisol habituation among women with abdominal fat distribution. Psychosom Med 1999;61:107.
36. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and cancer: fact or fiction? Eur J Cancer 1999;35(11):1603-7.
37. Glaser R, Kiecolt-Glaser JK, Marucha PT, MacCallum RC, Laskowski BF, Malarkey WB. Stress-related changes in proinflammatory cytokine production in wounds. Arch Gen Psychiatry 1999; 56(5):450-6.
38. Herberman R. Principles of tumor immunology. In: Holleb AI, Fink DJ, Murphy FP, editors.Textbookofclinical oncology. Atlanta, GA: American Cancer Society, 1991.pp.69-79.
39. Herberman R. Natural killer cell activity and antibody-dependent cell-mediated cytotoxicity. In: Rose N, Friedman H, Fahey J, editors. Manual of clinical laboratory immunology. Washington, DC: American Society for Microbiology, 1986.
40. Roder J, Pross H. The biology of the human natural killer cell. J Clin Immunol 1982;2:249-63.
41. Herbert T, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med 1993;55:364-79.
42. Landmann RM, Muller FB, Perini C, Wesp M, Erne P, Buhler FR. Changes of immunoregulatory cells induced by psychological and physical stress: relationship to plasma catecholamines. Clin Exp Immunol 1984;58(1):127-35.
43. Naliboff BD, Benton D, Solomon GF, Morley JE, Fahey JL, Bloom ER, Makinodan T, Gilmore SL. Immunological changes in young and old adults during brief laboratory stress. Psychosom Med 1991;53: 121-32.
44. Schedlowski M, Jacobs R, Stratmann G, Richter S, Hadicke A, Tewes U, Wagner TO, Schmidt RE. Changes of natural killer cells during acute psychological stress. J Clin Immunol 1993;13(2):119-26.
45. Schedlowski M, Falk A, Rohne A, Wagner TO, Jacobs R, Tewes U, Schmidt RE. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells. J Clin Immunol 1993; 13(5):344-51.
46. Cacioppo JT, Poehlmann KM, Kiecolt-Glaser JK, Malarkey WB, Burleson MH, Berntson, GG, Glaser R. Cellular immune responses to acute stress in female caregivers of dementia patients and matched controls. Health Psychol 1998;17(2):182-9.
47. Benschop RJ, Geenen R, Mills PJ, Naliboff BD, Kiecolt-Glaser JK, Herbert TB, van der Pompe G, Miller GE, Matthews KA, Godaert GL, Gilmore SL, Glaser R, Heijnen CJ, Dopp JM, Bijlsma JW, Solomon GF, Cacioppo JT. Cardiovascular and immune responses to acute psychological stress in young and old women: a meta-analysis. Psychosom Med 1998;60(3):290-6.
48. Kiecolt-Glaser JK, Garner W, Speicher C, Penn GM, Holliday J, Glaser R. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med 1984;46(1):7-14.
49. Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 1994;13(4):291-8.
50. Kiecolt-Glaser JK, Fisher LD, Ogrocki P, Stout JC, Speicher CE, Glaser R. Marital quality, marital disruption, and immune function. Psychosom Med 1987;49(1):13-34.
51. Irwin M, Daniels M, Smith TL, Bloom E, Weiner H. Impaired natural killer cell activity during bereavement. Brain Behav Immun 1987; 1(1):98-104.
52. Whiteside TL, Herberman RB. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 1995;7(5): 704-10.
53. Levy S, Herberman RB, Maluish AM, Schlien B, Lippman M. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 1985;4(2):99-113.
54. Levy S, Herberman RB, Lippman M, d'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 1987;5(3):348-53.
55. Levy S, Herberman RB, Lee J, Whiteside T, Kirkwood J, McFeeley S. Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model. Nat Immun Cell Growth Regul 1990;9(5): 313-24.
56. Levy S, Herberman RB, Whiteside T, Sanzo K, Lee J, Kirkwood J. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med 1990;52(1):73-85.
57. Levy S, Herberman RB, Lippman M, d'Angelo T, Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 1991;17(2):67-75.
58. Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N, Fahey JL. A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures. Arch Gen Psychiatry 1990;47(8):729-35.
59. Sapolsky RM, Donnelly TM. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology 1985;117(2):662-6.
60. Ben-Eliyahu S, Yirmiya R, Liebeskind JC, Taylor AN, Gale RP. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun 1991;5(2): 193-205.